No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Achievements and Progress Heading Into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
While Institutions Own 25% of Cardiff Oncology, Inc. (NASDAQ:CRDF), Retail Investors Are Its Largest Shareholders With 57% Ownership
James Levine Bought 13% More Shares In Cardiff Oncology
10 Health Care Stocks With Whale Alerts In Today's Session
Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $10
Cardiff Oncology Is Maintained at Overweight by Piper Sandler